Clinical trial
The Effect of Hyperbaric Oxygen Therapy on Kidney Function, Perfusion, Fibrosis and Proteinuria in Diabetic Patients With Diabetic Kidney Disease
NCT03376282 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Hyperbaric Oxygen Therapy on Kidney Function, Perfusion, Fibrosis and Proteinuria in Diabetic Patients With Diabetic Kidney Disease
- Lead sponsor
- Assaf-Harofeh Medical Center
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 1, 2015
- Completion date
- May 4, 2020
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic renal failure